Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 8Gastrointestinal 4Gynecologic 2Tumor-Agnostic 1Other solid neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1CNS 1

Conditions

Histiocytosis, Non-Langerhans-Cell 1Histiocytosis, Langerhans-Cell 1Castleman Disease 1

Interventions

Cyclophosphamide 166Rituximab 155Specimen Handling 114Biopsy 91Magnetic Resonance Spectroscopy 90Vincristine 85Doxorubicin 79Prednisone 78fludarabine 69venetoclax 67obinutuzumab 62ibrutinib 54Lenalidomide 53Dexamethasone 53Cytarabine 47Methotrexate 44acalabrutinib 42Etoposide 41CT-P10 40blinatumomab 38fludarabine phosphate 34Bendamustine Hydrochloride 34prednylidene 32Gemcitabine 32deltacortene 31Calcium Dobesilate 30zanubrutinib 29pembrolizumab 29glofitamab 28Nivolumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genetic Testing × Lymphoid × 90 days × Clear all
NCT05028621 2026-05-07

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Case Comprehensive Cancer Center

Phase NA Suspended
135 enrolled
LymphoidMyeloid

Castleman Disease, Histiocytosis, Langerhans-Cell, Histiocytosis, Non-Langerhans-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡